Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qing-Dai maintenance vs withdrawal in ulcerative colitis remission
jRCTs071180073Completed
- Start
- Aug 2017
- Countries
- 1
01
Overview
Randomised trial of indigo naturalis in autoimmune colitis (2 arms). Primary endpoint: Remission rate at week 52. Started Aug 2017; status: completed.
02
Drugs
indigo naturalis
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCTs071180073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180073.